Skip to content

Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar

Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05293652
Enrollment
60
Registered
2022-03-24
Start date
2021-09-01
Completion date
2022-02-15
Last updated
2022-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar, Hydrocortisone, Iontophoresis, Phonophoresis

Brief summary

The purpose of this study will be to compare the effect of hydrocortisone iontophoresis and hydrocortisone phonophoresis on the treatment of surgical scar and overall scar appearance.

Detailed description

Scar contractures develop and extend to the underlying connective tissue and then muscles, leading to reduction in joint range of motion and affecting the day-to-day activities. Most patients (irrespective of age, gender and ethnicity) believe that even a small improvement in scarring is worthwhile , any research that may help improve scar outcome is meaningful. The need of this study has developed from the rarity of information about the difference between the effectiveness of iontophoresis and phonophoresis in enhancing the overall appearance of surgical scar.

Interventions

Hydrocortisone iontophoresis

Hydrocortisone Phonophoresis

OTHERtraditional PT program

Ultrasound and deep friction massage

Sponsors

Horus University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Both genders * same approach of medications * scar size varies from 5-15 cm

Exclusion criteria

* have cardiac / pacemakers * have significant health problems * obese patients (BMI more than 30) * uncooperative patients

Design outcomes

Primary

MeasureTime frameDescription
Scar pliabilityat baseline and after 3 months of interventionassessment of change in Scar pliability by using tonometer device

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026